Chemotherapy and management of bladder tumours
Open Access
- 1 March 2000
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 85 (5) , 599-610
- https://doi.org/10.1046/j.1464-410x.2000.00566.x
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- 2-YEARS EXPERIENCE WITH PACLITAXEL/CARBO- PLATIN AS FIRST LINE THERAPY IN METASTATIC BLADDER CANCERJournal of Urology, 1999
- A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinumEuropean Journal Of Cancer, 1998
- p53 nuclear immunoreactivity as a predictor of response and outcome following chemotherapy for metastatic bladder cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- p53 and treatment of bladder cancerNature, 1997
- Methotrexate, Vinblastine, Doxorubicin and Cisplatin Chemotherapy and Cystectomy for Unresectable Bladder CancerJournal of Urology, 1996
- Paclitaxel, Cisplatin and Methotrexate Combination Chemotherapy is Active in the Treatment of Refractory Urothelial MalignanciesJournal of Urology, 1995
- Adjuvant Polychemotherapy of Nonorgan-Confined Bladder Cancer After Radical Cystectomy Revisited: Long-Term Results of a Controlled Prospective Study and Further Clinical ExperienceJournal of Urology, 1995
- The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The memorial sloan-kettering cancer center experienceCancer, 1994
- Staging invasive bladder tumorsJournal of Surgical Oncology, 1992
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988